Company Filing History:
Years Active: 2009-2024
Title: **Chau-Ching Liu: Innovator in Lupus Diagnostics**
Introduction
Chau-Ching Liu is a prominent inventor based in Pittsburgh, PA, recognized for his contributions to the field of biomedical research and diagnostics. With a total of six patents to his name, Liu's work focuses primarily on innovative methods for diagnosing and monitoring autoimmune diseases, particularly lupus.
Latest Patents
Chau-Ching Liu's latest patents include groundbreaking advancements in lupus diagnostics. One patent introduces "Methods and systems using C4 gene copy number and cell-bound complement activation products for the identification of lupus and pre-lupus." This invention integrates cell-bound complement activation product profiling with C4 gene copy number assessment to serve as biomarkers for diagnosing and monitoring lupus.
Another significant patent is titled "Cell-bound complement activation product assays as companion diagnostics for antibody-based drugs." This innovation provides methods, systems, and kits that aid in determining whether a patient is likely to benefit from antibody therapy. In this context, the identification of cell-bound complement activation products associated with B lymphocytes plays a crucial role as diagnostic biomarkers.
Career Highlights
Throughout his career, Chau-Ching Liu has worked with esteemed institutions, including the Allegheny-Singer Research Institute and the University of Pittsburgh. His research has significantly advanced the understanding of autoimmune disorders and has contributed to the development of targeted therapies.
Collaborations
Liu has collaborated with notable colleagues, including Joseph M. Ahearn and Susan M. Manzi, further enriching his research through diverse insights and expertise. The synergy among these professionals has helped to push the boundaries of lupus research and diagnostics.
Conclusion
Chau-Ching Liu's innovative work and patents in lupus diagnostics illustrate the potential of scientific research to improve patient care. His contributions not only enhance diagnostic accuracy but also pave the way for tailored therapies, benefiting numerous patients suffering from autoimmune diseases.